• Science & Technology

'BRCA1-free' birth isn’t a "slippery slope to designer babies"

30 January 2009

Prostate cancer deaths double in men with BRCA2

Men with prostate cancer caused by a faulty BRCA2 gene are more than twice as likely to die from the disease than those carrying the faulty BRCA1 gene - reveals a study published in the British Journal of Cancer* today (Tuesday). Men with prostate cancer caused by a faulty BRCA2 gene are more than twice as likely to die from the disease than those carrying the faulty BRCA1 gene - reveals a study published in the British Journal of Cancer* today (Tuesday).

24 June 2008

Cancer Research UK scientists help narrow the search for BRCA1 carriers

Cancer Research UK scientists have identified a new test which may help narrow the search for breast cancer patients likely to carry the faulty BRCA1 gene. Cancer Research UK scientists have identified a new test which may help narrow the search for breast cancer patients likely to carry the faulty BRCA1 gene.

9 August 2005

Scientists uncover how BRCA2 regulates DNA repair

Cancer Research UK scientists have discovered a `molecular switchї that controls an essential DNA repair process, a study published in Nature1 reveals today. Cancer Research UK scientists have discovered a `molecular switchї that controls an essential DNA repair process, a study published in Nature1 reveals today.

30 March 2005

Charity to make breast cancer (BRCA2) gene freely available across Europe

Cancer Research UK today secured a Europe-wide patent on the hereditary breast cancer gene BRCA2, in a move that will be welcomed by scientists across the continent. Cancer Research UK today secured a Europe-wide patent on the hereditary breast cancer gene BRCA2, in a move that will be welcomed by scientists across the continent.

11 February 2004

• Health & Medicine

BRCA1 gene points way to targeting breast cancer treatment

Testing tumours for the breast cancer gene BRCA1 could be a powerful way of predicting how patients will respond to chemotherapy, scientists from Breast Cancer Campaign and Cancer Research UK report. Testing tumours for the breast cancer gene BRCA1 could be a powerful way of predicting how patients will respond to chemotherapy, scientists from Breast Cancer Campaign and Cancer Research UK report.

25 September 2003

How mutant BRCA2 causes cancer

Scientists believe they have uncovered one of the cancer-causing secrets of the breast cancer gene BRCA2. Scientists believe they have uncovered one of the cancer-causing secrets of the breast cancer gene BRCA2.

20 November 2002

• Health & Medicine

UK NSC recommends targeted prostate cancer screening

The UK NSC has recommended targeted prostate cancer screening for men with a BRCA2 gene change and a family history of linked cancers. It's an important step towards more personalised, risk‑based screening, and could help detect prostate cancer earlier in the people with the highest risk. The UK NSC has recommended targeted prostate cancer screening for men with a BRCA2 gene change and a family history of linked cancers. It's an important step towards more personalised, risk‑based screening, and could help detect prostate cancer earlier in the people with the highest risk.

28 May 2026

• Policy & Insight
• Health & Medicine

First steps towards a targeted prostate cancer screening programme

The UK NSC's proposed programme would invite 45 to 61-year-old men with BRCA mutations for prostate cancer screening every two years. Here's what it means and what will happen next. The UK NSC's proposed programme would invite 45 to 61-year-old men with BRCA mutations for prostate cancer screening every two years. Here's what it means and what will happen next.

28 November 2025